We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Robotic Platform Makes Coronary Angioplasty Procedures Easier and Safer

By HospiMedica International staff writers
Posted on 17 May 2023

Coronary heart disease is a common condition that arises due to blocked or narrowed coronary arteries. More...

Coronary angioplasty is a procedure used to widen these arteries. Although these procedures are generally safe, they do carry certain risks. Now, a new robot system for heart surgery not only makes the procedures safer and easier but also reduces radiation-induced injuries.

Robocath (Rouen, France) has launched its new robotic platform, R-One+, for coronary angioplasties. The R-One+ consists of two components: a command unit and the robotic unit itself. The robotic unit includes the robot and its articulated support arm, which boasts millimeter precision. This setup enables the cardiologist to control devices from the control command unit, which can be placed in the catheterization laboratory (cath lab) or the control room.

The R-One+ has been designed to offer physicians dependable, precise support during procedures, improving intervention conditions, particularly by providing complete protection from X-rays. The architecture of this medical robot allows the use of guidewires, balloons, and stent catheters (not simultaneously). It is compatible with leading devices on the market, such as guidewires, stent/balloons, imaging systems, and more. The robot can be set up in just a few minutes and seamlessly integrates into the intervention protocol, with no need for any additional steps.

Related Links:
Robocath 


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.